PCORI will host a multi-stakeholder workshop via teleconference/webinar for a discussion of how PCORI may best invest in an update of the Agency for Healthcare Research and Quality's (AHRQ) systematic review of the evidence around the use of newer oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation.

This will serve as one of the first efforts of a new initiative PCORI is launching, known as the Evidence Synthesis Program, to conduct syntheses of existing research studies on a particular clinical question or topic to more quickly and efficiently clarify what is known and what evidence gaps may still exist. We will stand up one element of our new Evidence Synthesis initiative—the focused updating of select out-of-date systematic reviews of high import—in coordination with our friends at the Agency for Healthcare Research and Quality.

At the meeting, a broad group of stakeholders—including patients, clinicians, payers and industry—will be asked to provide input and guidance on this update effort.

Meeting Material